Autism (sometimes called autism spectrum disorder or ASD) is a group of related developmental disorders that may lead to significant social, communication and behavioral challenges.
Children with autism and related causes of developmental delay can benefit immensely from early intervention and appropriate care. Today approximately, 15-20 percent of children with autism have an associated genetic trait that can be identified using advanced technology.
The results of genetic testing is critical because, when used together as part of a comprehensive clinical observation, they may help to identify children with autism much sooner than is possible through behavior observation alone.
Eastern Biotech & Life Sciences, a pioneer of Genetic Testing Services in the UAE and the Middle East, recently started offering a chromosomal microarray (CMA) analysis to provide the parents and doctors with information about possible genetic causes of a child's symptoms.
The test includes personal genetic counseling, the most advanced testing technology available, analysis by medical experts, and a detailed, personalized report created specifically for the affected child and the child's doctor allowing the child to begin therapy as early as possible.
The American College of Medical Genetics recommends this type of analysis as a "first line test in the initial postnatal evaluation" for a range of conditions including ASD.
As the understanding of genetic results is very important, the testing service also features a personalized genetic consultation.
